top of page
elena.png

ELENA SOU

PhD student

Elena completed her BSc at the University of East Anglia which she followed with an MSc in Cancer Research from the University of Glasgow under the supervision of Dr Michie. Following completion of her MSc Elena became a Research Assistant at the Northern Institute for Cancer Research (Newcastle) working with Dr Strathdee in 2017-18. Afterwards Elena embarked on an MRes at the University of Edinburgh where she worked with Prof Pollard and Prof Mill. After completing her MRes she moved to Liverpool to start her PhD in the McClurg lab in October 2019.

​

Publications:

Zhang J, Hu Z, Chung HH, Tian Y, Lau KW, Ser Z, Lim YT, Sobota RM, Leong HF, Chen BJ, Yeo CJ, Tan SY, Xuan K, Jian T, Dennis EK, Sou IF, McClurg UL, Lakshmanan M, Vaiyapuri TS, Raju A, Wong ES, Miin T, Vinay R, Ravisankar P, Elina T, Wai L, Tan EY and Tee WW (2023) Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. Nature communications, 14(1):2439

Sou IF, Hamer G, Tee W-W, Vader G, McClurg UL (2022) Cancer and meiotic gene expression – two sides of the same coin? Current Topics in Developmental Biology 2023:151:43-68.

Sandhu S, Sou IF, Hunter JE, Salmon L, Wilson CL, Perkins ND, Hunter N, Davies OR, McClurg UL (2021). Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12. Communications Biology 

Sou IF, ..., Tee W-W, McClurg UL. (2021). Meiosis initiation: a story of two sexes in all creatures great and small. Biochemical Journal 478 (20): 3791–3805.

Gangoso, Southgate, Bradley, Rus, Galvez-Cancing, McGivern, Güç, KapouraniByron, Ferguson, AlfazemaMorrisonGrantBlin, Sou, et al.; (2021) Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 184, 2454–2470

Tennant, Foster, Dodd, Sou, McPhie, Younger, Murphy, Pearson, Vernay, Keighren, Budd, Hart, Megaw, Boulter, Mill (2020) Fluorescent in vivo editing reporter (FIVER): A novel multispectral reporter of in vivo genome editing. BIORXIV

​

Elena Sou: Our Team
bottom of page